Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Orgenesis Inc (ORGS)

Orgenesis Inc (ORGS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 129,499
  • Shares Outstanding, K 24,480
  • Annual Sales, $ 7,650 K
  • Annual Income, $ 1,110 K
  • 60-Month Beta 0.92
  • Price/Sales 16.22
  • Price/Cash Flow N/A
  • Price/Book 2.17
Trade ORGS with:

Options Overview

Details
  • Implied Volatility 70.65%
  • Historical Volatility 43.22%
  • IV Percentile 22%
  • IV Rank 38.82%
  • IV High 123.74% on 05/13/21
  • IV Low 36.96% on 04/09/21
  • Put/Call Vol Ratio 2.00
  • Today's Volume 3
  • Volume Avg (30-Day) 49
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 2,077
  • Open Int (30-Day) 2,166

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.39
  • Growth Rate Est. (year over year) +256,253.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.56 +12.28%
on 07/20/21
5.49 -6.74%
on 06/28/21
+0.22 (+4.49%)
since 06/23/21
3-Month
4.14 +23.67%
on 05/13/21
6.47 -20.87%
on 05/06/21
-0.05 (-0.97%)
since 04/23/21
52-Week
4.14 +23.67%
on 05/13/21
8.30 -38.31%
on 03/12/21
-0.52 (-9.22%)
since 07/23/20

Most Recent Stories

More News
Orgenesis Achieves Multiple Ranpirnase Development Milestones

FDA Pre-IND consultation completed; submission of phase 2 trial of Ranpirnase for anogenital warts on schedule

ORGS : 5.12 (-3.21%)
Orgenesis announces use of the Tissue Genesis Icellator(R) in a Hospital for Special Surgery clinical study for rotator cuff repair

Orgenesis Inc. (NASDAQ: ORGS) ("Orgenesis" or the "Company"), a global biotech company working to unlock the full potential of cell and gene therapies, announces that enrollment has commenced for a clinical...

ORGS : 5.12 (-3.21%)
Orgenesis to Present at the Summer Solstice Conference - Best Ideas from the Buy-Side on June 2nd

Orgenesis Inc. (NASDAQ: ORGS) ("Orgenesis" or the "Company"), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it will be presenting at the...

ORGS : 5.12 (-3.21%)
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021

The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor...

RDHL : 6.93 (-2.53%)
PHO : 55.82 (+1.34%)
ECOR : 1.0100 (-0.98%)
MKTY : 7.28 (-2.02%)
SLNG : 8.37 (+2.07%)
CECE : 7.03 (+0.86%)
MKGI : 2.27 (+7.08%)
AUUD : 3.11 (-1.27%)
ARHH : 1.7850 (+0.20%)
DLPN : 8.07 (-2.54%)
IMAC : 1.5100 (-8.48%)
COMS : 1.8900 (-5.03%)
MYO : 8.77 (-4.57%)
MRVFF : 1.0490 (-7.17%)
MINM : 3.82 (+2.69%)
DTST : 4.16 (-16.80%)
NLSP : 2.93 (-0.68%)
AWH : 4.88 (-0.61%)
ISDR : 27.99 (-0.21%)
BMRA : 3.67 (-6.14%)
ALIM : 8.91 (-1.87%)
LFMD : 10.06 (-0.40%)
ANDA : 9.20 (+3.37%)
BIOL : 0.5887 (-3.21%)
FBIO : 3.06 (-2.86%)
DHX : 3.85 (-3.02%)
MLSS : 1.7300 (-4.42%)
ORGS : 5.12 (-3.21%)
ELYS : 3.96 (-2.22%)
THBRF : 3.2900 (+1.86%)
NMRD : 7.96 (+2.45%)
DXR : 9.96 (-2.45%)
Orgenesis First Quarter 2021 Revenue Increases 400% to $9.4 Million Reflecting Initial Success of POCare Platform

Achieves operating profit for the first quarter of 2021

ORGS : 5.12 (-3.21%)
FDA Approves Orgenesis IDE for Pilot Clinical Trial of its Tissue Genesis Icellator2(R) to Treat ARDS Resulting from COVID-19 Infection

IDE approval provides important validation of clinical development plans for the Icellator2

ORGS : 5.12 (-3.21%)
Orgenesis Schedules First Quarter 2021 Business Update Conference Call

Orgenesis Inc. (NASDAQ: ORGS) ("Orgenesis" or the "Company"), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it plans to host a conference...

ORGS : 5.12 (-3.21%)
Vibe Growth Corporation Announces Closing of Palm Springs Dispensary Acquisition

Sacramento, California--(Newsfile Corp. - May 4, 2021) - Vibe Growth Corporation () () () (the "" or ""), a vertically integrated California cannabis enterprise, is pleased to announce the closing of its...

ORGS : 5.12 (-3.21%)
VBSCF : 0.4801 (+5.38%)
VIBE.CN : 0.600 (+7.14%)
Jushi Holdings Inc. Completes Acquisition of Two California Retail Dispensaries

Jushi Holdings Inc. ("Jushi" or the "Company") (CSE: JUSH) (OTCMKTS: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it has closed on its previously announced acquisition...

ORGS : 5.12 (-3.21%)
JUSH.CN : 6.310 (-2.47%)
JUSHF : 5.0700 (-2.12%)
Avoid These Downgraded Stocks in Q2

Checking our POWR Ratings service before you buy a stock is a great way to get a second opinion. Stocks that are rated a Buy or Strong Buy are likely to outperform in the months ahead, while stocks that...

IMTE : 3.84 (-2.29%)
ORGS : 5.12 (-3.21%)
GNLN : 3.57 (+0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Orgenesis, Inc. is a biopharmaceutical company. It focused on developing its trans-differentiation technologies for diabetes. The company deals with the combination of cell-based therapy and regenerative medicine into clinical development. Its operating segment consists of Contract Development and Manufacturing...

See More

Key Turning Points

3rd Resistance Point 5.63
2nd Resistance Point 5.47
1st Resistance Point 5.29
Last Price 5.12
1st Support Level 4.95
2nd Support Level 4.79
3rd Support Level 4.61

See More

52-Week High 8.30
Fibonacci 61.8% 6.71
Fibonacci 50% 6.22
Fibonacci 38.2% 5.73
Last Price 5.12
52-Week Low 4.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar